Iron Hills Therapeutics, Inc

Arbela Laboratories, Inc., based in Randolph, NJ, is a pioneering company dedicated to addressing global health and resource crises by harnessing the power of Pichia pastoris, a novel yeast known for its rich protein and fiber content. Their innovative processing technology enables the production of affordable, sustainable nutrition, aiming for net-zero greenhouse gas emissions with minimal land and water use, while eliminating the need for fertilizers and pesticides. Recognizing the urgent need to balance the demand for protein-rich foods with the preservation of natural resources, Arbela Laboratories is committed to transforming the current food system. By focusing on sustainable solutions, the company aspires to contribute to a healthier world and tackle the escalating rates of chronic illnesses linked to modern dietary habits. Generated from the website

Lonza Inc, based in Walkersville, MD, is a company that specializes in providing innovative solutions for the life sciences industry. With a focus on research, development, and manufacturing, Lonza Inc offers a range of products and services to support the advancement of scientific discoveries and medical breakthroughs. Generated from their business information

BioInvenu Corporation, based in East Hanover, NJ, is a biotech company specializing in the development of proprietary cell-based assay products and services tailored for drug discovery researchers. Utilizing its innovative LinkLight technology, BioInvenu focuses on elucidating protein-protein interactions through highly sensitive assays that target G-protein coupled receptors, nuclear hormone receptors, and receptor tyrosine kinases. The company's mission is to advance the understanding of cellular signal transduction and support the identification of biologically relevant compounds that modulate these interactions. With exclusive licensing of the LinkLight technology, BioInvenu is committed to expanding its intellectual property rights while providing cutting-edge solutions for complex drug targets. Generated from the website